ANTX vs CSGP · $32.0M cap vs P/E 484, rev $1.82B
AN2 Therapeutics Inc (ANTX) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
ANTX does not have a complete income-statement cache yet.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
ANTX currently screens at market cap $32.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the ANTX and CSGP stock pages for the full models.
Not investment advice.